Literature DB >> 15129034

[The assessment of anxiety levels in patients with posttraumatic stress disorder].

Ebru Sinici1, Cemil Yildiz, Servet Tunay, Hüseyin Ozkan, Mehmet Altinmakas.   

Abstract

OBJECTIVES: The purpose of this study was to measure state and trait anxiety levels of veterans who developed posttraumatic stress disorder following combat or landmine injuries, or vehicle accidents.
METHODS: The anxiety levels of 98 veterans (mean age 20 years; range 18 to 25 years) were measured with the use of the State-Trait Anxiety Scale (STAI I-II). Diagnosis of posttraumatic stress disorder was made on the basis of the Structured Clinical Interview for DSM III-R.
RESULTS: The number of patients with high levels of anxiety was not in significant relationship with education level and trauma type (p>0.05). Regardless of education levels and trauma types, the number of patients with high trait anxiety significantly outweighed the number of patients with high state anxiety (p<0.05). Trait anxiety levels differed significantly between primary school and high school graduates (p=0.03).
CONCLUSION: Veterans should be under close supervision to determine and treat increased anxiety which worsens the quality of life. Special attention should be paid to appropriate psychological rehabilitation throughout the treatment plan.

Entities:  

Mesh:

Year:  2004        PMID: 15129034

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  2 in total

1.  State and trait anxiety levels of adolescents in a changing society, Kirikkale city, Turkey.

Authors:  Ömer Oğuztürk; Selda Hızel Bülbül; Nurper Erberk Özen; Mehmet Ekici; Kemal Örnek; Erdal Ünlü; Serhat Yüksel
Journal:  J Clin Psychol Med Settings       Date:  2012-06

2.  Patients with isolated musculoskeletal trauma have lower mental status scores.

Authors:  Koray Unay; Omer Karatoprak; Nadir Sener; Melih Guven; Abdullah Bilge
Journal:  Clin Orthop Relat Res       Date:  2008-06-05       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.